Cardiac Tissue Engineering for the Treatment of Myocardial Infarction

Poor cell engraftment rate is one of the primary factors limiting the effectiveness of cell transfer therapy for cardiac repair. Recent studies have shown that the combination of cell-based therapy and tissue engineering technology can improve stem cell engraftment and promote the therapeutic effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Dongmin, Wang, Xiaowei, Ye, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617685/
https://www.ncbi.nlm.nih.gov/pubmed/34821706
http://dx.doi.org/10.3390/jcdd8110153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617685/
https://www.ncbi.nlm.nih.gov/pubmed/34821706
http://dx.doi.org/10.3390/jcdd8110153

Ejemplares similares